JPRN-UMIN000015736
Completed
未知
Allogeneic hematopoietic stem cell transpalntation using Thymoglobulin for patients with T-cell malignancy - AlloHSCT with ATG for T-cell malignancy
ConditionsT-cell malignancy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- T-cell malignancy
- Sponsor
- ational Cancer Center Hospital
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) severe organ failure (2\) uncontrolled hypertension (3\) HIV infection (4\) uncontrolled active infection (5\) uncontrolled CNS invasion (6\) pregnancy (7\) psychological disorder (8\) allergy to drugs used in this study (9\) if the physician consider as inappropriate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Allogeneic hematopoietic stem cell transplantation for elderly patientsJPRN-UMIN000017744nivesity of Tokyo Hospital, Department of Hematology and Oncology50
Completed
Not Applicable
Allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-haploidentical related donor using reduced dose of posttransplantation high-dose cyclophosphamide (PTCy) for poor prognosis or refractory hematological malignancies (OCU16-2)Acute myeloid leukemia(AML) Acute lymphoblastic leukemia(ALL) Acute leukemias of ambiguous lineage Myelodysplastic syndrome(MDS) Chronic myeloid leukemia(CML) Adult T-cell leukemia/lymphoma(ATLL) Malignant lymphoma(ML)JPRN-UMIN000026028Osaka City University33
Recruiting
Phase 2
Allogeneic hematopoietic stem cell transplantation from HLA6/8-4/8 matched related donor for poor prognostic or refractory hematologic malignancy and solid tumor - Ibaraki Children's Hospital phase II studyAcute leukemia, malignant lymphoma, and solid tumorJPRN-UMIN000027010Ibaraki Children's Hospital30
Completed
Phase 2
Allogeneic hematopoietic stem cell transplantation for aplastic anemia using low-dose anti-thymocyte globuliJPRN-UMIN000006071Kanto Study Group for Cell Therapy28
Active, not recruiting
Phase 1
Stem cells transplant from matched donor in patients with chronic myeloid leukemia who do not improve with TKI therapyChronic Myeloid LeukemiaMedDRA version: 18.0Level: LLTClassification code 10054352Term: Chronic phase chronic myeloid leukemiaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-003126-40-ITIVERSITà DEGLI STUDI MILANO BICOCCA20